January 29, 2015 7:58 AM ET

Pharmaceuticals

Company Overview of Affectis Pharmaceuticals AG

Company Overview

Affectis Pharmaceuticals AG, a pharmaceutical company, engages in developing drugs for the treatment of neurodegenerative and neuroinflammatory diseases. It engages in developing AFC-5128, a potent CNS-penetrant oral P2X7 antagonist for the treatment of neuropathic pain and multiple sclerosis; and AFC-08, a monoclonal antibody and biological drug for the treatment of psychiatric disorders. Affectis Pharmaceuticals AG was formerly known as Neuronova AG and changed its name to Affectis Pharmaceuticals AG in January 2005. The company was founded in 2002 and is based in Dortmund, Germany. As of January 7, 2014, Affectis Pharmaceuticals AG operates as a subsidiary of LDC Beteiligungen UG (haftung...

Otto-Hahn-Straße 15

Dortmund,  44227

Germany

Founded in 2002

Phone:

49 231 9742 7000

Fax:

49 231 9742 7039

Key Executives for Affectis Pharmaceuticals AG

Chief Executive Officer
Co-Founder and Member of Supervisory Board
Founder and Member of the Scientific Advisory Board
Chief Medical Officer
Age: 51
Director of Behavioural Pharmacology
Compensation as of Fiscal Year 2014.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Affectis Pharmaceuticals AG, please visit www.affectis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.